We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test first received FDA approval in April 2021 for assessing the eligibility of patients with endometrial cancer for treatment with GSK’s Jemperli. Read More